| QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial EF Wedam, GE Bigelow, RE Johnson, PA Nuzzo, MCP Haigney Archives of internal medicine 167 (22), 2469-2475, 2007 | 308 | 2007 |
| Furosemide and the progression of left ventricular dysfunction in experimental heart failure JM McCurley, SU Hanlon, S Wei, EF Wedam, M Michalski, MC Haigney Journal of the American College of Cardiology 44 (6), 1301-1307, 2004 | 172 | 2004 |
| Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation CM Andrews, MJ Krantz, EF Wedam, MJ Marcuson, JF Capacchione, ... Cardiology Journal 16 (3), 210-217, 2009 | 74 | 2009 |
| An unusual case of cardiac glycoside toxicity D Kassop, MS Donovan, BM Cohee, DL Mabe, EF Wedam, JE Atwood International journal of cardiology 170 (3), 434-437, 2014 | 24 | 2014 |
| The clinical significance of QT interval prolongation in anesthesia and pain management: what you should and should not worry about C Spevak, C Hamsher, CQ Brown, EF Wedam, MC Haigney Pain Medicine 13 (8), 1072-1080, 2012 | 22 | 2012 |
| The impact of opioids on cardiac electrophysiology EF Wedam, MC Haigney Current Cardiology Reviews 12 (1), 27-36, 2016 | 16 | 2016 |
| Catheter Ablation of Atrial Fibrillation Should Be Offered as Primary Therapy: What’s Your Hurry? EF Wedam, MCP Haigney Cardiac Electrophysiology Clinics 7 (3), 385-393, 2015 | 2 | 2015 |
| Opioid addiction agonist therapy and the QT prolongation phenomenon: state of the science and evolving research questions. EF Wedam, MC Haigney Addiction 108 (6), 2013 | 2 | 2013 |
| The thorough QT study: Let’s be precise EF Wedam, MC Haigney Cardiology Journal 18 (4), 341-342, 2011 | 1 | 2011 |
| Bifocal right ventricular pacing: Bail-out or cop-out? EF Wedam, MC Haigney Cardiology Journal 17 (1), 1-3, 2010 | 1 | 2010 |
| Progressive OT prolongation despite a fixed dose: More problems for HERG blockers? EF Wedam, GE Bigelow, F Johnson, M Haigney CIRCULATION 112 (17), U552-U553, 2005 | | 2005 |
